drugset / Trial / NCT05317455

Regulation of Brain Glucose Metabolism in Type 1 Diabetes

NCT05317455

Phase 0 Recruiting 16 enrolled Yale University
RandomizedCrossoverDouble-blindTreatment

Summary

This is a prospective randomized placebo-controlled double-blind crossover pilot study determining the effect of dichloroacetate on brain function under clamped hypoglycemia in T1DM.

Timeline

Start
2025-05-13
Primary completion
2027-05-01
Completion
2027-06-30

Drugs

EvaluationDrugModalityDoseRoute
Comparator Dichloroacetate Small molecule Oral